# The FreMRI Study: Advanced MRI on Migraine Patients Treated With Fremanezumab

> **NCT06244823** · PHASE4 · UNKNOWN · sponsor: **Hospital Clínico Universitario de Valladolid** · enrollment: 87 (estimated)

## Conditions studied

- Migraine Disorders
- Migraine With Aura
- Migraine Without Aura
- Brain Diseases

## Interventions

- **DRUG:** Fremanezumab Prefilled Syringe

## Key facts

- **NCT ID:** NCT06244823
- **Lead sponsor:** Hospital Clínico Universitario de Valladolid
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2024-02-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06244823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06244823, "The FreMRI Study: Advanced MRI on Migraine Patients Treated With Fremanezumab". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06244823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*